Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seider, N
Right arrow Articles by Oliven, A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Seider, N
Right arrow Articles by Oliven, A

Chest, Vol 104, 1070-1074, Copyright © 1993 by American College of Chest Physicians

ARTICLES

Cardiac arrhythmias after inhaled bronchodilators in patients with COPD and ischemic heart disease

N Seider, EG Abinader and A Oliven
Department of Medicine B, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Selective beta 2-agonist aerosols may produce significant cardiovascular effects. In the present study we used Holter monitoring to compare the arrhythmogenic effects of inhaled terbutaline (TE), a beta 2-agonist, with that of ipratropium bromide (IB), a nonabsorbable cholinergic drug. Fourteen patients with concomitant obstructive lung disease, ischemic heart disease, and complaints of postinhalation palpitations were studied in a random, double-blind, cross-over fashion. Both drugs significantly improved vital capacity and FEV1. Heart rate and the frequency of premature beats were not significantly affected by the bronchodilators. We conclude that no clear connection between inhaled bronchodilators and arrhythmias could be demonstrated.


This article has been cited by other articles:


Home page
 ChestHome page
G. T. Ferguson, C. Funck-Brentano, T. Fischer, P. Darken, and C. Reisner
Cardiovascular Safety of Salmeterol in COPD
Chest, June 1, 2003; 123(6): 1817 - 1824.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.